Today

Agents

Chat

Arena

Discover

More

App

Prenetics restates FY2024, FY2023 results in audited annual report amendment - PRE News | Rallies

Prenetics restates FY2024, FY2023 results in audited annual report amendment

PRE•2026-09-04

Amended annual report restates prior-year revenue figures

Prenetics filed an amended annual report with restated FY2024 and FY2023 comparative revenue figures.

FY2025 revenue from continuing operations rose to USD 92.39 million from USD 15.94 million in FY2024.
FY2025 loss for the year narrowed to USD 39.98 million from USD 49.81 million a year earlier.
IM8 generated USD 60.1 million of FY2025 revenue; CircleDNA contributed USD 12.95 million.
Adjusted EBITDA loss was USD 18.07 million, versus USD 17.73 million in FY2024.

Related News

HA Sustainable Infrastructure slips after UBS downgrades stock

HASI•2026-09-04

Nasdaq Trade Halt <IPEX.O> Volatility Trading Pause at 12:28 PM

IPEX•2026-09-04

Nasdaq trade halt continues <UCFI.O> reason not available at 11:55 AM

Sources

S

Prenetics restates FY2024, FY2023 results in audited annual report amendment

Sec

2026-09-04

SoundHound AI Says Selling Securityholders May Resell 36.9 Mln Common Shares, Sec Filing Shows

SOUN•2026-09-04

Wheat continues slide with Ukraine war negotiations in focus

WEAT•2026-09-04